"Targeting Transcriptional Addiction in Cancer" (TACTIC) is funded by the DKH!


Within the special funding program: "Preclinical Drug Development" our project TACTIC is funded.

Deutsche Krebshilfe

We are very excited that our network project TACTIC is funded by the DKH and that we can thus jointly create a national center for drug research in oncology in an outstanding network of established groups from chemical biology, drug discovery as well as oncologists from the universities of Frankfurt, Dortmund, Tübingen, Würzburg, the TU Munich, the MPI and the Leibniz Institute Dortmund.